Egyptian lab group IDH (Integrated Diagnostics Holdings) is using Egypt’s more settled political situation to cash in on mega-profits. The group expects a market capitalisation of $600m at IPO and could float up to 45% of the share capital. Before tax profits came to $21m, a margin of 25%, in the financial year ending 30 Sep 2014, on sales of $87m, up 27.5%. EBITDA margin stands at 42%.